[Federal Register Volume 70, Number 157 (Tuesday, August 16, 2005)]
[Notices]
[Page 48169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-16165]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Pub. L. 92-463, notice is hereby given of the meeting 
of the Substance Abuse and Mental Health Services Administration 
(SAMHSA) Drug Testing Advisory Board on September 7-8, 2005.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.
    The Board will also meet to develop the analytical and 
administrative policies for the final revisions to the Mandatory 
Guidelines for Federal Workplace Drug Testing Program that were 
published as proposed revisions in the Federal Register on April 13, 
2004 (69 FR 19673). The submissions from 285 commenters have been made 
available to the public on the Web site http://workplace.samhsa.gov. 
This meeting will be conducted in closed session since discussing such 
public comments in open session and then developing the policies will 
significantly frustrate the Department's ability to develop the final 
notice of revisions to the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs. The HHS Office of General Counsel made the 
determination that such matters are protected by exemption 9(B) of 
section 552b(c) of title 5 U.S.C. and therefore may be closed to the 
public.
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (http://workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.

    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: September 7-8, 2005.
    Place: Residence Inn by Marriott, 7335 Wisconsin Avenue, 
Bethesda, Maryland 20814.
    Type: Open: September 7, 2005; 8:30 a.m.-9:30 a.m.
    Closed: September 7, 2005; 9:30 a.m.-4:30 p.m.
    Closed: September 8, 2005; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke 
Cherry Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 
(telephone) and 240-276-2610 (fax), e-mail: 
[email protected].

    Dated: August 9, 2005.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. 05-16165 Filed 8-15-05; 8:45 am]
BILLING CODE 4162-20-P